Kyle W. Gano

2016

In 2016, Kyle W. Gano earned a total compensation of $2.3M as Chief Business Development Officer at Neurocrine Biosciences.

Compensation breakdown

Bonus$155,250
Option Awards$734,916
Salary$345,000
Stock Awards$1,014,918
Other$4,363
Total$2,254,447

Gano received $1M in stock awards, accounting for 45% of the total pay in 2016.

Gano also received $155.3K in bonus, $734.9K in option awards, $345K in salary and $4.4K in other compensation.

Rankings

In 2016, Kyle W. Gano's compensation ranked 4,358th out of 14,075 executives tracked by ExecPay. In other words, Gano earned more than 69.0% of executives.

ClassificationRankingPercentile
All
4,358
out of 14,075
69th
Division
Manufacturing
1,532
out of 5,488
72nd
Major group
Chemicals And Allied Products
462
out of 1,900
76th
Industry group
Drugs
335
out of 1,543
78th
Industry
Biological Products, Except Diagnostic Substances
63
out of 287
78th
Source: SEC filing on April 17, 2019.

Gano's colleagues

We found five more compensation records of executives who worked with Kyle W. Gano at Neurocrine Biosciences in 2016.

2016

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2016

Timothy Coughlin

Neurocrine Biosciences

Chief Financial Officer

2016

Christopher O'Brien

Neurocrine Biosciences

Chief Medical Officer

2016

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

2016

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

News

You may also like